Search clinical trials for: TAK-379
Total 4943 results
-
Millennium Pharmaceuticals, Inc.CompletedSystemic Lupus Erythematosus | Lupus Erythematosus, SystemicUnited States
-
TakedaCompletedMyasthenia GravisUnited States, Spain, Canada, Serbia, Italy, Poland
-
TakedaRecruitingGeneralized Pustular Psoriasis | Erythrodermic PsoriasisJapan
-
TakedaRecruitingRenal Impairment | Healthy VolunteersUnited States
-
TakedaCompletedAutoimmune DiseaseUnited Kingdom
-
TakedaNot yet recruiting
-
TakedaActive, not recruitingPrimary Immune ThrombocytopeniaSpain, United States, Croatia, Italy, China, Germany, Bulgaria, Greece, Slovenia, Japan, Ukraine
-
TakedaRecruiting
-
TakedaCompletedSleep Initiation and Maintenance DisordersUnited States
-
TakedaCompletedInsomnia | Major Depressive DisorderJapan
-
TakedaCompletedInsomniaUnited States
-
TakedaCompletedChronic InsomniaUnited States
-
TakedaNimbus Lakshmi, Inc.CompletedPsoriatic ArthritisUnited States, Czechia, Germany, Poland
-
Northwestern UniversityTakedaTerminatedParkinsonism | REM Behavior DisorderUnited States
-
TakedaCompleted
-
TakedaCompletedChronic InsomniaUnited States, Australia, France, Germany, Belgium, Finland, Russian Federation, Italy, Czech Republic
-
TakedaCompleted
-
TakedaCompletedCircadian DysregulationUnited States
-
TakedaCompletedChronic InsomniaUnited States
-
TakedaTerminated
-
TakedaCompletedSleep Disorders, Circadian RhythmUnited States
-
TakedaCompletedChronic InsomniaUnited States, Canada
-
TakedaCompleted
-
TakedaCompletedSleep Initiation and Maintenance Disorders
-
TakedaActive, not recruitingGlomerulonephritis | Kidney DiseaseTaiwan, Australia, Hungary, Spain, United Kingdom, United States, China, Korea, Republic of, Italy, Japan, Singapore
-
TakedaRecruitingHealthy Volunteers | Hepatic ImpairmentUnited States
-
TakedaCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
TakedaCompletedSleep Apnea, ObstructiveUnited States
-
TakedaCompletedChronic Obstructive Pulmonary Disease | COPDUnited States
-
TakedaTerminatedDiabetes MellitusUnited States
-
Chong Kun Dang PharmaceuticalCompletedClinical Study to Compare the Pharmacokinetics and Safety of D113 With CKD-349 in Healthy VolunteersChronic Renal FailureKorea, Republic of
-
TakedaCompletedChronic InsomniaUnited States
-
TakedaNimbus Lakshmi, Inc.; Innovaderm Research Inc.CompletedModerate to Severe Plaque PsoriasisUnited States, Canada
-
Chong Kun Dang PharmaceuticalCompletedRheumatoid ArthritisKorea, Republic of
-
Henan Cancer HospitalNot yet recruitingApplication of Douyin in Patients With Bone and Soft Tissue Malignant Tumors During PerichemotherapyChemotherapy | Malignant Tumor
-
Kaohsiung Medical University Chung-Ho Memorial...Completed
-
Chong Kun Dang PharmaceuticalCompletedType II Diabetes MellitusKorea, Republic of
-
Henan Cancer HospitalNot yet recruitingPerioperative Period | Malignant Tumor of Bone
-
University of TasmaniaEnrolling by invitationDementia | Alzheimer Disease | Speech Disorders | Movement AbnormalitiesAustralia
-
Oregon Research InstituteRecruitingAging | Mild Cognitive Impairment | Accidental FallsUnited States
-
Chong Kun Dang PharmaceuticalCompleted
-
US Department of Veterans AffairsCompleted
-
Afyonkarahisar Health Sciences UniversityRecruiting
-
St. Luke's-Roosevelt Hospital CenterCompletedSubstance-Related Disorders | End Stage Liver Disease | End Stage Renal DiseaseUnited States
-
Chong Kun Dang PharmaceuticalActive, not recruitingType II Diabetes MellitusKorea, Republic of